Praxis Investment Management Inc. Increases Stake in Synopsys, Inc. $SNPS
by Scott Moore · The Cerbat GemPraxis Investment Management Inc. raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.0% in the second quarter, Holdings Channel reports. The institutional investor owned 6,980 shares of the semiconductor company’s stock after acquiring an additional 330 shares during the period. Praxis Investment Management Inc.’s holdings in Synopsys were worth $3,579,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. S Bank Fund Management Ltd increased its position in Synopsys by 1.7% in the second quarter. S Bank Fund Management Ltd now owns 11,996 shares of the semiconductor company’s stock worth $6,150,000 after buying an additional 195 shares in the last quarter. Turtle Creek Wealth Advisors LLC purchased a new position in Synopsys during the second quarter valued at $540,000. WealthPlan Investment Management LLC grew its position in shares of Synopsys by 27.7% during the second quarter. WealthPlan Investment Management LLC now owns 5,426 shares of the semiconductor company’s stock valued at $2,782,000 after purchasing an additional 1,177 shares in the last quarter. Mutual Advisors LLC grew its holdings in Synopsys by 6.0% during the 2nd quarter. Mutual Advisors LLC now owns 1,133 shares of the semiconductor company’s stock valued at $581,000 after buying an additional 64 shares in the last quarter. Finally, Curated Wealth Partners LLC purchased a new position in shares of Synopsys in the second quarter valued at $202,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys Price Performance
Synopsys stock opened at $440.20 on Friday. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. The stock has a market cap of $81.77 billion, a price-to-earnings ratio of 34.55, a price-to-earnings-growth ratio of 4.80 and a beta of 1.10. The firm has a 50-day moving average of $529.15 and a two-hundred day moving average of $510.15. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same quarter in the previous year, the firm posted $3.43 EPS. The firm’s revenue for the quarter was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, research analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.
Analyst Upgrades and Downgrades
SNPS has been the subject of a number of recent research reports. Wells Fargo & Company dropped their target price on Synopsys from $630.00 to $550.00 and set an “equal weight” rating for the company in a report on Wednesday, September 10th. BNP Paribas assumed coverage on shares of Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target for the company. Baird R W lowered Synopsys from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 10th. Rosenblatt Securities restated a “neutral” rating and set a $605.00 target price (down previously from $650.00) on shares of Synopsys in a research report on Wednesday, September 10th. Finally, Stifel Nicolaus dropped their price objective on Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Ten investment analysts have rated the stock with a Buy rating, five have given a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $569.67.
View Our Latest Analysis on Synopsys
Insider Buying and Selling at Synopsys
In other news, CFO Shelagh Glaser sold 3,655 shares of the company’s stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the completion of the sale, the chief financial officer owned 15,317 shares of the company’s stock, valued at approximately $9,339,847.09. This represents a 19.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the sale, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at $10,278,468. The trade was a 32.48% decrease in their position. The disclosure for this sale can be found here. Insiders sold 30,894 shares of company stock valued at $16,760,783 in the last ninety days. 0.62% of the stock is owned by insiders.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- The Basics of Support and Resistance
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- 3 Warren Buffett Stocks to Buy Now
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).